A source-linked view of every Goserelin study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.
Largest indexed study
5,101 participants · NCT03701334 →Developer / research origin
AstraZeneca
Evidence summary
Goserelin appears in 75 indexed studies: 25 recruiting, 11 completed and 13 with registry results posted. The highest registered development stage in this snapshot is Phase 4. These counts measure registry activity; they do not establish that Goserelin is safe or effective.
Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.
Current studies
Completed studies
Stopped studies
National Cancer Institute (NCI) · Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8
Phase 3
Active, not recruiting
608
2026-07
ECOG-ACRIN Cancer Research Group · Prostate Carcinoma
Phase 3
Active, not recruiting
27
2026-07
RenJi Hospital · Prostate Cancer · Prostate
Phase 2
Not yet recruiting
200
2026-07
Washington University School of Medicine · Breast Cancer · Cancer of Breast
Phase 2
Recruiting
50
2026-07
Aristotle University Of Thessaloniki · Metabolic Dysfunction-Associated Steatotic Liver Disease · Nonalcoholic Fatty Liver
Phase 4
Active, not recruiting
62
2026-07
Mayo Clinic · Recurrent Castration-Sensitive Prostate Carcinoma · Recurrent Prostate Cancer
Phase 2
Recruiting
532
2026-07
Novartis · Breast Cancer
Phase 2
Completed
327
2026-07
Fudan University · Breast Cancer Female · HER2-negative Breast Cancer
Not applicable
Completed
14
2026-07
Stanford University · Prostate Adenocarcinoma · Stage I Prostate Cancer
Not applicable
Completed
146
2026-07
NRG Oncology · Stage I Prostate Adenocarcinoma AJCC v7 · Stage II Prostate Adenocarcinoma AJCC v7
Phase 2 / Phase 3
Completed
612
2026-06
Praful Ravi, MB BCHir, MRCP · Metastatic Prostate Cancer · Non-metastatic Prostate Cancer
Phase 1
Completed
9
2026-06
National Cancer Institute (NCI) · Castrate Sensitive Prostate Cancer
Phase 2
Completed
12
2026-05
National Cancer Institute (NCI) · Prostatic Neoplasms
Phase 1
Terminated
12
2026-06
EQRx, Inc. · Advanced Breast Cancer
Phase 2
Terminated
100
2026-05
Jiangsu HengRui Medicine Co., Ltd. · Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Phase 3
Terminated
391
2026-04
Full study index
Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.
75 matching studies
Last registry update first
Latest publications
Related pages
Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.